Xtal Concepts
Xtal Concepts GmbH, founded 2012 in Hamburg, Germany, develops and markets laboratory instruments based on dynamic light scattering (DLS) for protein crystallographers, structural biology researchers, and pharmaceutical drug discovery teams.
- Company typePrivate
- Founded2012
- HeadquartersHamburg, Germany
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Xtal Concepts does
Xtal Concepts GmbH is a Hamburg-based technology company founded in 2012 that develops, manufactures, and markets laboratory instruments for the characterization of nano- and microparticles in liquids, with a core focus on dynamic light scattering (DLS). Its instruments target protein crystallographers, structural biology researchers, and pharmaceutical drug discovery teams who need to assess sample quality, screen buffer conditions, monitor aggregation, and qualify samples for downstream techniques such as X-ray crystallography and cryo-EM. The product portfolio centers on the SpectroLight 600/610 benchtop systems, which perform fully automated in-plate DLS particle sizing using sample volumes as low as 0.08–1 µl in standard 96-well plates, combined with integrated microscopy and optional UV/fluorescence imaging. Complementary products include the SpectroQ plate hotel for fully automated DLS and imaging, the XtalController for interactive real-time crystallization control, and the XtalLight 100/200/210 series for UV imaging and crystal identification.
The business model is primarily hardware sales of specialized laboratory instruments, with revenue generated through one-time instrument purchases, custom-engineered systems developed for institutional clients (notably EMBL Hamburg and the European Space Agency), and application support services. Distribution is direct, with a dedicated sales team covering Europe and Rest of World from Hamburg and a separate sales contact for the Americas. The go-to-market motion relies heavily on scientific conferences (ECM, PSDI, German Crystallographic Society meetings, ISBC, FEBS courses), educational webinars, peer-reviewed publications, and academic course sponsorship, rather than high-volume digital marketing. Customers split between pharmaceutical/biotech companies and academic and public research institutions, with named collaborators including Domainex and CrystalsFirst in the PROTAC drug discovery segment.
Xtal Concepts holds two key patent families protecting its technology: European Patent EP2 588 649 B1 and US Patent US 9,284,659 B2 cover its core in-plate DLS device for monitoring crystallization, while EP3 739 321 B1 and US 11,609,171 cover a Cryo-EM sample qualification method, signaling a deliberate strategic extension from crystallography into the adjacent cryo-EM workflow. The company received initial funding from IFB Innovationsstarter in 2012. It is privately held, with Dr. Annette Eckhardt listed as managing director in the Hamburg commercial register (HRB 122799), and operates with 11–50 employees from its Hamburg headquarters at Schnackenburgallee 13.
Xtal Concepts firmographics
Firmographics- Name
- Xtal Concepts
- Legal name
- Xtal Concepts GmbH
- Website
- https://xtal-concepts.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Xtal Concepts GmbH, founded 2012 in Hamburg, Germany, develops and markets laboratory instruments based on dynamic light scattering (DLS) for protein crystallographers, structural biology researchers, and pharmaceutical drug discovery teams.
- Ownership category
- akta.pro rank
Xtal Concepts industry classification
Industry- Product category
- Laboratory Instrumentation for Structural Biology
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE)
- akta.pro secondary industry
- Analytical Instruments & Chromatography Systems (HLAGAIAA)
Keywords
Where Xtal Concepts is headquartered
LocationHeadquarters
- HQ city
- Hamburg
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Xtal Concepts business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Laboratory Instruments (DLS Systems): Sale of specialized laboratory instruments including SpectroLight 600/610, SpectroQ, XtalController, XtalLight systems. Instruments are manufactured in small series with customized systems developed for specific research institutions. Revenue is one-time hardware sales with potential for service/maintenance contracts.
- Customized Instrument Development: Development of customized systems for public research institutions (e.g., EMBL Hamburg, ESA), likely involving custom engineering projects with associated revenue.
- Application Support Services: Technical and application support services provided to customers, including method development and optimization consulting.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom quotation-based pricing |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels6 records
Xtal Concepts product offering
Product offeringCore offering
Xtal Concepts designs, manufactures, and sells benchtop and automated laboratory instruments that characterize nano- and microparticles in liquids through patented in-plate Dynamic Light Scattering (DLS). The SpectroLight 600/610, SpectroQ, XtalController, and XtalLight product lines measure hydrodynamic radius and image crystallization drops in standard 96-well plates using sample volumes as low as 0.08–1 µl, supporting protein crystallographers, structural biologists, and pharmaceutical drug discovery workflows.
Product overview
Xtal Concepts develops, produces, and markets laboratory instruments for the characterization of nano- and microparticles in liquids based on dynamic light scattering (DLS). The product portfolio centers on the SpectroLight 600/610 instrument series as the primary DLS and imaging platform, complemented by the SpectroQ plate hotel system for automated DLS and imaging, the XtalController for interactive crystallization, and the XtalLight series (100, 200/210) for UV/fluorescence imaging. Together, these products enable sample quality analysis, buffer screening, workflow monitoring, and crystal identification from sub-microlitre sample volumes in standard multi-well plates.
Differentiator
Problem solved
Functional benefit
Products and services
- SpectroLight 600 Benchtop instrument for fully automated Dynamic Light Scattering (DLS) particle sizing in sub-microlitre sample volumes (0.08–1 µl) using standard 96-well plates, with an integrated laboratory microscope and optional UV/fluorescence imaging for crystal identification. Targeted at protein crystallographers, pharmaceutical drug discovery groups, and structural biology researchers.
- SpectroLight 610 Variant of the SpectroLight 600 benchtop DLS instrument with in situ DLS capabilities, demonstrated at the HTCC5 conference in 2023 and used by Xtal Concepts customers for protein sample characterization.
- SpectroQ Fully automated plate hotel system combining Dynamic Light Scattering and imaging with temperature-controlled storage and processing of crystallization plates under constant temperature conditions, extending application range beyond state-of-the-art imaging systems for structural biology workflows.
- XtalController Interactive crystallization device enabling real-time monitoring of molecular interactions with simultaneous control of protein/precipitant concentration, temperature, evaporation rate, and particle size distribution. Supports cryo protection, cross-linking, and nanocrystal production for structural biology and cryo-EM workflows.
- XtalLight 200/210 Fully automated desktop imaging system for high-speed imaging of standard crystallization plates, with bright light and UV imaging in LCP, automated drop finding, and trace fluorescence imaging capabilities for protein crystallography and structural biology users.
- XtalLight 100 UV-light source upgrade adaptable to laboratory microscopes, used to excite intrinsic tryptophan fluorescence so users can distinguish salt crystals from protein crystals during crystallization plate inspection.
Quantifiable outcome
- Sample volume reduction from months of cuvette work to one week using 72/96-well plates
- +3 more outcomes
Companies that use Xtal Concepts
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
Xtal Concepts technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
Xtal Concepts partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core, collaborative and partner.
- European Molecular Biology Laboratory (EMBL) HamburgcoreCustomized system development partnership with EMBL Hamburg for specialized instruments tailored to their structural biology research requirements. EMBL is a premier public research institution.
- European Space Agency (ESA)coreCustomized system development for ESA research applications, demonstrating the company's capability to develop specialized instruments for unique research environments.
- University of Lübeck - Zentrum für Infektiologie und Entzündungsforschung, Structural VirologycollaborativeOngoing collaboration with the Structural Virology group at University of Lübeck for research applications of DLS technology in infection and inflammation research.
- Douglas Instruments LtdpartnerCollaboration with Douglas Instruments Ltd, a UK-based company specializing in protein crystallization instrumentation. Douglas House, East Garston, Berkshire, RG17 7HD, United Kingdom.
- DomainexcollaborativeOngoing cooperation with Domainex, a drug discovery services company, providing services including structural biology support and protein production. Xtal Concepts supported Domainex's 20th anniversary in 2021.
- CrystalsFirstcollaborativeCooperation partnership with CrystalsFirst, a structural biology and drug discovery company. CrystalsFirst provided samples and advice for PROTAC-induced complex validation studies using SpectroLight 600. CrystalsFirst has a track record of >60 structurally-enabled drug targets and partnerships with companies including AiCuris, Flindr Therapeutics, KSQ Therapeutics, Merck KGaA, and Think Bioscience.
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
Xtal Concepts competitors and assessment
Company assessmentDirect peers
- Molecular Dimensions: Molecular Dimensions supplies protein crystallization instrumentation, screens, and consumables to the same academic and pharma structural biology market Xtal Concepts serves. They offer crystallization imaging and analysis tools that overlap with Xtal's XtalLight line, and were acquired by Bruker in 2023, increasing competitive pressure on crystallization-imaging segments.
- Douglas Instruments: Douglas Instruments manufactures protein crystallization instrumentation and is also an explicit technology/integration partner of Xtal Concepts. Both companies serve the same structural biology customers with complementary crystallization and DLS/imaging tools, making them a strategic competitor-as-partner in the crystallization workflow.
- Wyatt Technology: Wyatt Technology specializes in light scattering instrumentation (DLS, MALS, SLS) for protein characterization and is used by the same structural biology and biopharma customers as Xtal Concepts. Their DynaPro NanoReader and Plate Reader III are particularly competitive in micro-volume and plate-based DLS, making them the closest direct competitor to the SpectroLight 600.
- TTP Labtech: TTP Labtech's mosquito and dragonfly liquid handlers are standard tools in crystallization and cryo-EM sample preparation workflows. While they focus on pipetting versus DLS, they target the same protein crystallography customer segment with automation products that complement or compete with Xtal's automated plate-handling systems.
- Hampton Research: Hampton Research is a leading supplier of crystallization screens, plates, and instrumentation for macromolecular crystallography. They target the same protein crystallographer customer base as Xtal Concepts and offer crystallization imaging systems; the customer overlap in structural biology core facilities is nearly complete.
- Malvern Panalytical: Malvern Panalytical's Zetasizer range is the dominant commercial DLS platform for protein/particle sizing. Directly comparable to Xtal Concepts' SpectroLight 600 in application (DLS particle sizing) and customer base (structural biology, pharma, academia), though Malvern historically relied on cuvette-based formats versus Xtal's patented in-plate approach.
Broad incumbents
- Sartorius: Sartorius's lab products division supplies liquid handling, cell line, and protein characterization consumables and instruments to biopharmaceutical labs. They compete with Xtal Concepts for budget allocations in the same biopharma QC and discovery workflows, particularly in protein characterization and sample preparation.
- Bruker: Bruker is a major structural biology instrument provider whose portfolio spans crystallography (X-ray sources, detectors), cryo-EM (acquisition of Molecular Dimensions and previous Vutara acquisition), and biophysical characterization. They are a broad incumbent covering protein crystallographers' workflows end-to-end, with substantially greater resources than Xtal Concepts.
- Thermo Fisher Scientific: Thermo Fisher sells the Talos/D-Class cryo-EM instruments and broader analytical and life-science instrumentation that competes for the same bench space and budgets as Xtal Concepts in pharma and academic labs. Their broad portfolio and large installed base in structural biology make them a key adjacent incumbent.
Emerging players
- Refeyn: Refeyn commercializes mass photometry technology (single-molecule mass measurement in solution), an emerging alternative for protein characterization that addresses similar workflow pain points to Xtal's DLS platforms (low-sample-volume analysis of protein stoichiometry, aggregation, complex formation). They target the same structural biology customer base with a complementary and potentially disruptive technology.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Xtal Concepts social profiles
Digital presenceXtal Concepts financial estimates
Financial estimateRevenue estimate
Valuation estimate
Xtal Concepts leadership team
Management profileNumber of profiles
Profiles4 records
Xtal Concepts funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Xtal Concepts M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Xtal Concepts
What does Xtal Concepts do?
Xtal Concepts designs, manufactures, and sells benchtop and automated laboratory instruments that characterize nano- and microparticles in liquids through patented in-plate Dynamic Light Scattering (DLS). The SpectroLight 600/610, SpectroQ, XtalController, and XtalLight product lines measure hydrodynamic radius and image crystallization drops in standard 96-well plates using sample volumes as low as 0.08–1 µl, supporting protein crystallographers, structural biologists, and pharmaceutical drug discovery workflows.
Is Xtal Concepts a public or private company?
Xtal Concepts is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Xtal Concepts founded?
Xtal Concepts was founded in 2012. It employs 11 to 50 people.
Where is Xtal Concepts based?
Xtal Concepts is headquartered in Hamburg, Germany, in the Europe region.
How does Xtal Concepts make money?
Three revenue lines are on record. Laboratory Instruments (DLS Systems) is the primary driver. The others are customized Instrument Development and application Support Services.
Who are Xtal Concepts's main competitors?
Direct peers on record are Molecular Dimensions, Douglas Instruments, Wyatt Technology, TTP Labtech, Hampton Research and Malvern Panalytical. Broad incumbents are Sartorius, Bruker and Thermo Fisher Scientific. Refeyn is listed as an emerging player.
Does Xtal Concepts have an API?
No public API is recorded for Xtal Concepts.
What industry is Xtal Concepts in?
Xtal Concepts's product category is Laboratory Instrumentation for Structural Biology. Its primary akta.pro industry code is HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments, with a secondary code of HLAGAIAA, Analytical Instruments & Chromatography Systems. Its NAICS code is 334516 and its SIC code is 3826.